Covered recipient · General Payments record
JEFFREY L EVANS
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$18,802.76
- Reported across 307 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,078.97 | 55 |
| Travel and Lodging | $1,980.12 | 4 |
| Consulting Fee | $800.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PROCEPT BioRobotics Corporation | $1,980.12 | 4 |
| VERATHON INC. | $800.00 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $206.79 | 3 |
| Sumitomo Pharma America, Inc. | $199.00 | 6 |
| BLUEWIND MEDICAL | $195.20 | 2 |
| COLOPLAST CORP | $156.47 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $139.93 | 3 |
| Astellas Pharma Global Development | $131.61 | 1 |
| Laborie Medical Technologies Corp. | $121.57 | 1 |
| Innovation Technologies Inc | $115.14 | 1 |
| Janssen Biotech, Inc. | $93.70 | 3 |
| Antares Pharma, Inc. | $77.25 | 3 |
| Ferring Pharmaceuticals Inc. | $68.58 | 3 |
| 180 Medical, Inc. | $66.74 | 3 |
| UROGEN PHARMA, INC. | $66.74 | 3 |
| BAXTER HEALTHCARE | $59.64 | 2 |
| ACCORD HEALTHCARE, INC. | $48.83 | 2 |
| Endo USA, Inc. | $48.34 | 3 |
| ABBVIE INC. | $36.54 | 2 |
| Telix Pharmaceuticals | $36.40 | 1 |
| Ambu Inc. | $36.20 | 1 |
| Astellas Pharma US Inc | $31.78 | 1 |
| Blue Earth Diagnostics Limited | $24.28 | 1 |
| Teleflex LLC | $21.49 | 1 |
| Merck Sharp & Dohme Corporation | $20.90 | 1 |
| Endo Pharmaceuticals Inc. | $20.87 | 1 |
| IMMUNITYBIO, INC. | $19.66 | 1 |
| PFIZER INC. | $17.77 | 1 |
| BECTON, DICKINSON AND COMPANY | $17.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (60)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.